Supernus Pharmaceuticals, Inc. logo

SUPNSupernus Pharmaceuticals, Inc.

SUPN Stock Price, Valuation & Chart | Supernus Pharmaceuticals, Inc.

Compare

SUPN Historical price chart

SUPN Key Stats

Market Capitalization2.21B
PE Ratio12.38
EPS3.06
Trading Volume1.44M
Today's High/Low39.45/37.62
Dividend Yield0.00
52 Week High/Low59.68/37.54
Shares Outstanding58.22M
SUPN Financial Statement
SUPN Analyst ratings
SUPN Analysis & performance metrics

SUPN Company profile

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS)…

SUPN Management team

Management
Frank Mottola
Senior Vice President of Quality, GMP Operations, Information Technology and Regulatory Affairs
Taylor Raiford
Senior Vice President of Sales
Kevin T. Anderson Esq.
Compliance Officer
Jack A. Khattar M.B.A.CEO
Founder, President, Chief Executive Officer, Secretary & Director
Todd Horich M.B.A., Ph.D.
Senior Vice President of Marketing, Commercial Operations & Market Access
Jeff Bozick
Senior Vice President of Supply Chain
Jonathan Rubin M.B.A., M.D.
Senior Vice President of Research & Development and Chief Medical Officer
Bryan A. Roecklein Ph.D.
Senior Vice President of Corporate Development
Total 8 executives

SUPN Frequently asked questions

What is Supernus Pharmaceuticals, Inc. (SUPN) Stock Price?

Current stock price of Supernus Pharmaceuticals, Inc. (SUPN) stock is $37.880. The stock price is -4.27% lower in the session. The intraday range can be seen from this page. Volume of Supernus Pharmaceuticals, Inc. (SUPN) stock is 1.44M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Supernus Pharmaceuticals, Inc. (SUPN) stock price going up or down today?

The stock price of Supernus Pharmaceuticals, Inc. (SUPN) can change with earnings, company news, and overall market sentiment. Supernus Pharmaceuticals, Inc. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Supernus Pharmaceuticals, Inc. stock expensive at its current price?

Whether Supernus Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SUPN on this page is 12.38. EPS on this page is 3.06. Compare those figures with peers and growth expectations before deciding if the current Supernus Pharmaceuticals, Inc. price is justified.

How has the stock price of Supernus Pharmaceuticals, Inc. (SUPN) performed historically?

Historical performance for Supernus Pharmaceuticals, Inc. (SUPN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SUPN reacted to past earnings and market events.

Should I buy Supernus Pharmaceuticals, Inc. (SUPN) stock, at this price?

Buying Supernus Pharmaceuticals, Inc. (SUPN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.